Skip to main content
Equibles

Carol Webb

Board Member

Citius Oncology, Inc. (CTOR)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Carol Webb

Carol Webb is recorded as Board Member at Citius Oncology, Inc. (CTOR). Citius Oncology, Inc. reported in an 8-K filed August 16, 2024 that Carol Webb was appointed Class II Director, effective August 12, 2024. Citius Oncology, Inc. reported in an 8-K filed August 5, 2024 that Carol Webb was appointed Director (Class II).

“Each of Mr. Myron Holubiak (Class I), Mr. Joel Mayersohn (Class I), Dr. Eugene Holuka (Class II), Mr. Robert Smith (Class II), Ms. Carol Webb (Class II), Mr. Suren Dutia (Class III), Mr. Leonard Mazur (Class III and Chairman) and Mr. Dennis McGrath (Class III) were elected to serve as directors of the Company.”
Citius Oncology, Inc. Form 8-K, filed August 16, 2024 · Read the filing
“a proposal to approve by ordinary resolution, the eight (8) persons listed below be elected to serve on New Citius Oncology Board upon the consummation of the Business Combination to serve staggered terms until the 2025 (Class I), 2026 (Class II) and 2027 (Class III) annual meetings of stockholders, as applicable, or until their respective successors are duly elected and qualified or until their earlier death, resignation, retirement or removal for cause”
Citius Oncology, Inc. Form 8-K, filed August 5, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Citius Oncology, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.